The clarifies baseball tickets event attracted nhl rockies spells out about 100 CEOs and senior executives from(bio)pharmaceutical companies, private equity and venture capital companies fromaround Europe and USA. The exclusive setting of the conference helpedparticipants learn, network and do business. The extremely positive feedbackreceived from attendees shows that EBE and BIO Deutschland efforts to create aselect platform to do business were successful. Despite the global financing situation the European biotechnology still showsincreasing innovation potential. According to an analysis recently published,the world`s six biggest-selling drugs in 2014 will all be biotech products,underlining the importance of the sector for the global pharmaceutical industry.During the conference innovative companies throughout Europe had the opportunityto present their last R&D achievements and novel business models.
Executivesfrom key biotech and international pharmaceutical companies, private equity andVC firms shared their experiences, presented case-studies and their viewsconcerning the key factors for facilitating growth of the European Biotechsector rockies blankets . The keynotes and panel discussions amongst others entered into aspects offinancing issues due to the global economic crisis: innovative financingpathways were presented and ways for positioning a company to attract investorsand other partners were discussed 258 words / 1884 charactersNOTES TO EDITORS:1 hockey rockies . The conference was kindly sponsored by the Bavarian Ministry of Economics andTechnology, BIOM Biotech Cluster Development, Merck Serono, BoehringerIngelheim, Roche and Amantec 2 todd helton . About EBE: European Biopharmaceutical Enterprises (EBE) is the European tradeassociation that represents biopharmaceutical companies of all sizes operatingin Europe baseball . EBE was established in 2000 as a specialised group of EFPIA and isheadquartered in Brussels. EBE actively promotes a favourable economic,business, scientific and regulatory environment for biopharmaceutical in Europeand also provides a wide range of value-added services to its 66 membercompanies. For more information: About BIO Deutschland: The Berlin-based Biotechnology Industry Organisationof Germany (BIO Deutschland), which has more than 230 members, includingcompanies, BioRegions and sector service providers, has set itself the target ofsupporting and promoting the development of an innovative economic sector basedon modern biosciences Further information is available at.
The full programme is available at http:// Download: This text is available at: http:// use - Please provide copy BIO Deutschland e.V.Dr rockys baseball . Pablo Serrano, Senior ManagerTegeler Weg 33 / berlinbiotechpark,10589 Berlin, GermanyTel.: +49-30-3450593-30, Fax: -59E-Mail: Copyright Business Wire 2009 colorado rockies . MOSCOW (Reuters) - Six-time NHL All Star Sergei Fedorov has signed a two-year contract with Metallurg Magnitogorsk, the Russian club said the colorado rocky mountains . Sports | RussiaFedorov, 39, was negotiating with several NHL teams but decided to return to Russia, ending an 18-year career which included winning three Stanley Cups with the Detroit Red Wings and capturing the Hart Trophy as the league MVP in 1994.He joined the Washington Capitals from Columbus in February 2008, helping them to the Stanley Cup playoffs for the past two seasons colorado rockies mountain . REDWOOD CITY, Calif., June 25 /PRNewswire/ -- MyoScience(R), Inc todayannounced that Joseph E.
Whitters, CPA former chairman of the board of MentorCorporation, was elected to the MyoScience board of directors coors field seating chart . Whitters joinedthe Mentor board in 2004, assuming the Chairman role soon thereafter.Mentorwas acquired by Johnson and Johnson (JNJ) in 2009 for $1.1 Billion.He alsoserves on the boards of directors of Omnicell, Luminent Mortgage Capital, andseveral private companies.From 1986 to 2005, Mr colorado rockies fantasy camp . Whitters was an executiveat First Health, serving as CFO for most of his tenure.During that periodthe company's revenues grew from $5 to $900 Million.It was acquired byCoventry Health Plans in 2005 for $1.8 Billion."Joe Whitters has an exceptionally strong financial and operationalbackground nhl rockies . Additionally, he has a deep industry experience in the health careand aesthetics areas.This very relevant experience and his critical insightinto the aesthetics market will greatly benefit a company at MyoScience'sstage," said Bob Curtis, MyoScience CEO."I believe MyoScience has some very innovative and unique aestheticstechnologies," said Whitters hockey rockies .
"I look forward to working with this dynamicteam and the board."Whitters will fill a board seat left vacant by the stepping down of MichaelPartsch, CEO of Accelemed, Inc., who has been a board member sinceMyoScience's initial funding.Mr Partsch will remain a board observer ian stewart autographed baseball . "MyoScience has made great strides since its initial funding," said MichaelPartsch."I am honored to have been part of that success as a board memberand am very excited about the opportunity available to the Company"."Mike Partsch has been a valuable board member since our A round offinancing," said Bob Curtis."We thank him for his seminal contributions tothe early success of MyoScience."About MyoScience, Inc.MyoScience, Inc., founded in 2005 with headquarters in Redwood City,California, is a clinical development stage company focused on developing anon-toxic treatment for dynamic facial wrinkles (frown lines between the browsand forehead and crow's feet lines).MyoScience received 510k clearance fromthe U.S todd helton . Food and Drug Administration for its device in 2009 for a generalindication.MyoScience is currently investigating applications in aesthetics baseball . Major investors in MyoScience, include De Novo Ventures, Accuitive MedicalVentures, Nexus Medical Partners, Saratoga Ventures, and Medicis Capital GmbH Press Contacts:Robert M . Curtis, President and CEOMyoScience, (650) 474-2600SOURCEMyoScience, Inc.Robert M. Curtis, President and CEO of MyoScience, Inc., +1-650-474-2600,.
Comments are closed.